XML 35 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Instruments And Hedging Activities (Narrative) (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended 6 Months Ended
Nov. 24, 2013
Nov. 25, 2012
Nov. 24, 2013
Nov. 25, 2012
Nov. 24, 2013
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Nov. 24, 2013
Commodities futures, swaps & options
Nov. 24, 2013
Minimum
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Nov. 24, 2013
Maximum
Employee-Directed Investments In Darden Stock Within The Non-Qualified Deferred Compensation Plan
Nov. 24, 2013
Darden Stock Units
Minimum
Nov. 24, 2013
Darden Stock Units
Maximum
Nov. 24, 2013
5.625% Senior Notes Due October 2012
Senior Notes
Oct. 31, 2012
5.625% Senior Notes Due October 2012
Interest rate swaps
Nov. 24, 2013
5.625% Senior Notes Due October 2012
Interest rate swaps
Senior Notes
Nov. 24, 2013
4.500% Senior Notes Due October 2021
Senior Notes
Sep. 30, 2013
6.200% Senior Notes Due October 2017
Senior Notes
Sep. 30, 2013
6.200% Senior Notes Due October 2017
Interest rate swaps
Senior Notes
Nov. 24, 2013
Forward contracts
Darden Stock Units
Derivative [Line Items]                                  
Contract expiration date           May 01, 2014                      
Notional value of derivative instrument                         $ 250,000,000     $ 100,000,000  
Face amount of debt                     350,000,000     400,000,000 500,000,000    
Interest rate of debt                     5.625%     4.50% 6.20%    
Maturity date of debt                     Oct. 01, 2012            
Ineffective portion of interest rate hedge     0                            
Notional value of swaps                       150,000,000          
Reduction to interest expense related to net swap settlements 600,000 900,000 1,100,000 2,100,000                          
Vesting period                 4 years 5 years              
Forward contract indexed to issuer's equity, indexed shares         0.3                       1.2
Common stock at forward contract rate             $ 47.07 $ 51.95 $ 31.19 $ 52.66              
Amount of loss reclassified from AOCI to earnings (effective portion)     $ (8,800,000)